Page 2 - Taiwanese (TAIEX) Pharmaceuticals & Biotech Dividend Stocks

UPDATED May 13, 2024

Discover Taiwanese Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the TAIEX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

51 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1762

Chunghwa Chemical Synthesis & Biotech
NT$46.700.4%-49.8%NT$3.6bNT$48.00PE13.7xn/a1.7%

6472

Bora Pharmaceuticals
NT$708.00-4.6%17.6%NT$71.4bNT$865.00PE23.6xE22.9%1.7%

4162

PharmaEngine
NT$92.60-0.9%0%NT$13.3bNT$106.00PE48.4xE17.5%1.6%

1760

Panion & Bf Biotech
NT$94.70-2.0%-32.4%NT$8.1bn/aPE105.1xn/a1.6%

4114

Synmosa Biopharma
NT$39.551.2%-2.0%NT$15.1bn/aPE25.4xn/a1.5%

4119

SCI Pharmtech
NT$91.803.7%-11.4%NT$11.0bn/aPE37.2xn/a1.4%

1795

Lotus Pharmaceutical
NT$279.00-7.0%1.3%NT$73.8bNT$390.20PE18.7xE25.7%1.2%

1783

Maxigen Biotech
NT$43.551.8%-24.9%NT$3.9bn/aPE25.9xn/a1.1%

1789

ScinoPharm Taiwan
NT$27.60-2.5%6.6%NT$21.8bNT$26.00PE56.7xn/a1.1%

4160

Genetics Generation Advancement
NT$53.50-6.3%17.0%NT$1.4bn/aPE47.6xn/a1.0%

1271

SunWay Biotech
NT$115.003.6%135.9%NT$6.8bn/aPE155xn/a0.9%

6620

Handa Pharmaceuticals
NT$140.5016.1%-15.4%NT$19.8bNT$200.00PE27.3xn/a0.7%

4130

Genovate Biotechnology
NT$23.70-1.3%-13.2%NT$2.6bn/aPE88.4xn/a0.6%

6785

Alar Pharmaceuticals
NT$240.50-9.8%34.4%NT$16.1bn/aPE39.1xn/a0.6%

4169

TCM Biotech International
NT$55.20-1.1%6.5%NT$3.3bNT$113.00PE175.5xn/a0.5%

6935

Prince Pharmaceutical
NT$29.857.4%-24.6%NT$1.1bn/aPE70.6xn/a0.5%

4167

Savior Lifetec
NT$22.854.8%36.4%NT$7.3bn/aPE241.5xn/a0.5%

6645

Kim Forest Enterprise
NT$37.80-4.2%26.5%NT$1.9bn/aPS4.6xn/a0.2%

4743

Oneness Biotech
NT$149.50-6.3%-23.0%NT$67.9bNT$262.00PS782.8xE46.9%0.06%

4127

Tien Liang BioTech
NT$38.70-3.9%159.7%NT$1.8bn/aPE99.9xn/a0%

4195

Genomics BioSci & Tech.Ltd
NT$19.25-0.3%-7.8%NT$1.4bn/aPS3.5xn/a0%

6562

UBI Pharma
NT$14.251.8%-62.3%NT$1.7bn/aPE2097.4xn/a0%

6661

Welgene BiotechLtd
NT$22.40-2.6%0.9%NT$522.0mn/aPS1.7xn/a0%

7561

Bioray Biotech
NT$19.25-16.7%-45.3%NT$579.1mn/aPS3xn/a0%
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.